5

Removal from labeling of 60-mg citalopram dose

Année:
2012
Langue:
english
Fichier:
PDF, 60 KB
english, 2012
7

Comorbid mood disorders and medical illness: a Food and Drug Administration perspective

Année:
2003
Langue:
english
Fichier:
PDF, 37 KB
english, 2003
8

Tolerance to the prolactin-elevating effect of neuroleptics

Année:
1981
Langue:
english
Fichier:
PDF, 400 KB
english, 1981
11

A Regulatory Perspective on Psychiatric Syndromes in Alzheimer Disease

Année:
2001
Langue:
english
Fichier:
PDF, 51 KB
english, 2001
13

Regulatory Issues in Pediatric Psychopharmacology

Année:
1996
Langue:
english
Fichier:
PDF, 6.05 MB
english, 1996
16

Suicidality in Pediatric Patients Treated With Antidepressant Drugs

Année:
2006
Langue:
english
Fichier:
PDF, 122 KB
english, 2006
18

Regulatory Issues on Behavioral and Psychological Symptoms of Dementia in the United States

Année:
2000
Langue:
english
Fichier:
PDF, 476 KB
english, 2000
19

FDA Perspective on the DSM-5 Approach to Classification of “Cognitive” Disorders

Année:
2011
Langue:
english
Fichier:
PDF, 60 KB
english, 2011
22

Why Are Innovative Drugs Failing in Phase III?

Année:
2017
Langue:
english
Fichier:
PDF, 438 KB
english, 2017